FI20011507A0 - Uusia yhdisteitä - Google Patents
Uusia yhdisteitäInfo
- Publication number
- FI20011507A0 FI20011507A0 FI20011507A FI20011507A FI20011507A0 FI 20011507 A0 FI20011507 A0 FI 20011507A0 FI 20011507 A FI20011507 A FI 20011507A FI 20011507 A FI20011507 A FI 20011507A FI 20011507 A0 FI20011507 A0 FI 20011507A0
- Authority
- FI
- Finland
- Prior art keywords
- new compounds
- compounds
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
- C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
- C07C217/90—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to a carbon atom of a six-membered aromatic ring, e.g. amino-diphenylethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
Priority Applications (30)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20011507A FI20011507A0 (fi) | 2001-07-10 | 2001-07-10 | Uusia yhdisteitä |
ARP020102586A AR036236A1 (es) | 2001-07-10 | 2002-07-10 | Inhibidores del mecanismo de intercambio na+/ca2+ y metodo para la inhibicion del mecanismo de intercambio na+/ca2+ en celulas y para el tratamiento de arritmias |
ES02755036T ES2269746T3 (es) | 2001-07-10 | 2002-07-10 | Compuestos, que son potentes inhibidores del mecanismo de intercambio na+/ca2+ y que son utiles en el tratamiento de arritmias. |
EA200400161A EA006580B1 (ru) | 2001-07-10 | 2002-07-10 | Новые соединения, являющиеся сильнодействующими ингибиторами механизма обмена ионов na+/ca2+ при лечении аритмии |
NZ530490A NZ530490A (en) | 2001-07-10 | 2002-07-10 | New compounds, which are potent inhibitors of Na+/Ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
US10/482,396 US7425568B2 (en) | 2001-07-10 | 2002-07-10 | Compounds, which are potent inhibitors of Na+ /Ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
SI200230422T SI1412343T1 (sl) | 2001-07-10 | 2002-07-10 | Spojine, ki so ucinkoviti inhibitorji mehanizma izmenjave Na+/Ca2+ in so uporabne pri zdravljenju aritmij |
EP02755036A EP1412343B1 (en) | 2001-07-10 | 2002-07-10 | Compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
IL15964702A IL159647A0 (en) | 2001-07-10 | 2002-07-10 | NEW COMPOUNDS, WHICH ARE POTENT INHIBITORS OF Na+/Ca2+ EXCHANGE MECHANISM AND ARE USEFUL IN THE TREATMENT OF ARRHYTHMIAS |
HU0400391A HUP0400391A3 (en) | 2001-07-10 | 2002-07-10 | New compounds, which are potent inhibitors of na+/ca2+ exchange and pharmaceutical compositions containing them |
AT02755036T ATE338038T1 (de) | 2001-07-10 | 2002-07-10 | Verbindungen, bei denen es sich um wirksame inhibitoren des na+/ca2+ austauschmechanismus handelt und die sich zur behandlung von arrhythmien eignen |
CNB028138635A CN1281597C (zh) | 2001-07-10 | 2002-07-10 | 可用作Na+/Ca2+交换机制的有效抑制剂并可用于治疗心律失常的新化合物 |
PCT/FI2002/000621 WO2003006452A1 (en) | 2001-07-10 | 2002-07-10 | New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
MXPA04000267A MXPA04000267A (es) | 2001-07-10 | 2002-07-10 | Compuestos novedosos, los cuales son inhibidores potentes del mecanismo de intercambio de na+/ca2+ y son utiles en el tratamiento de arritmias. |
KR10-2004-7000332A KR20040025697A (ko) | 2001-07-10 | 2002-07-10 | 소디움 이온/칼슘 이온 교환 메카니즘의 강력한저해제이며, 부정맥 치료에 유용한 신규 화합물 |
DK02755036T DK1412343T3 (da) | 2001-07-10 | 2002-07-10 | Forbindelser, som er stærke inhibitorer af Na+/Ca2+udbytningsmekanismen og er nyttige til behandling af arytmier |
DE60214388T DE60214388T2 (de) | 2001-07-10 | 2002-07-10 | Verbindungen, bei denen es sich um wirksame inhibitoren des na+/ca2+ austauschmechanismus handelt und die sich zur behandlung von arrhythmien eignen |
BR0211070-9A BR0211070A (pt) | 2001-07-10 | 2002-07-10 | Compostos inovadores que são inibidores potentes do mecanismo de troca na+/ca2+ e são úteis no tratamento de arritmias |
AU2002321339A AU2002321339B2 (en) | 2001-07-10 | 2002-07-10 | New compounds, which are potent inhibitors of NA+/CA2+ exchange mechanism and are useful in the treatment of arrhythmias |
CA2452918A CA2452918C (en) | 2001-07-10 | 2002-07-10 | New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
JP2003512224A JP4113839B2 (ja) | 2001-07-10 | 2002-07-10 | Na+/Ca2+交換機構の強力な阻害剤であり、不整脈の処置において有用である新規化合物 |
PT02755036T PT1412343E (pt) | 2001-07-10 | 2002-07-10 | Compostos que são potentes inibidores do mecanismo de permuta na+/ca2+ e úteis no tratamento de arritmias |
YUP-6/04A RS50886B (sr) | 2001-07-10 | 2002-07-10 | Nova jedinjenja koja su jaki inhibitori mehanizma za izmenu na+/ca2+ i korisni su kod lečenja aritmija |
PL02367958A PL367958A1 (en) | 2001-07-10 | 2002-07-10 | New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
UA2004020928A UA76168C2 (en) | 2001-07-10 | 2002-10-07 | COMPOUNDS BEING DRASTIC INHIBITORS OF Na+/Ca+2 EXCHANGE MECHANISM IN TREATMENT OF ARRHYTHMIA |
NO20035821A NO20035821L (no) | 2001-07-10 | 2003-12-23 | Nye forbindelser som er kraftige inhibitoer av Na<O>+</O>/Ca<O>+</O> utvekslingsmekanismer og som nyttige i behandlingen av arrytmier |
IL159647A IL159647A (en) | 2001-07-10 | 2003-12-30 | Compounds that suppress the activity of mechanase + NA + / CA² replacement and are useful in the treatment of disorders |
ZA200400145A ZA200400145B (en) | 2001-07-10 | 2004-01-08 | New compounds, which are potent inhibitors of Na<+>/Ca<2+> exchange mechanism and are useful in the treatment of arrhythmias. |
HR20040133A HRP20040133A2 (en) | 2001-07-10 | 2004-02-09 | NEW COMPOUNDS, WHICH ARE POTENT INHIBITORS OF Na+/Ca2+ EXCHANGE MECHANISM AND ARE USEFUL IN THE TREATMENT OF ARRHYTHMIAS |
HK05100708A HK1068611A1 (en) | 2001-07-10 | 2005-01-27 | New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20011507A FI20011507A0 (fi) | 2001-07-10 | 2001-07-10 | Uusia yhdisteitä |
Publications (1)
Publication Number | Publication Date |
---|---|
FI20011507A0 true FI20011507A0 (fi) | 2001-07-10 |
Family
ID=8561628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20011507A FI20011507A0 (fi) | 2001-07-10 | 2001-07-10 | Uusia yhdisteitä |
Country Status (28)
Country | Link |
---|---|
US (1) | US7425568B2 (sr) |
EP (1) | EP1412343B1 (sr) |
JP (1) | JP4113839B2 (sr) |
KR (1) | KR20040025697A (sr) |
CN (1) | CN1281597C (sr) |
AR (1) | AR036236A1 (sr) |
AT (1) | ATE338038T1 (sr) |
AU (1) | AU2002321339B2 (sr) |
BR (1) | BR0211070A (sr) |
CA (1) | CA2452918C (sr) |
DE (1) | DE60214388T2 (sr) |
DK (1) | DK1412343T3 (sr) |
EA (1) | EA006580B1 (sr) |
ES (1) | ES2269746T3 (sr) |
FI (1) | FI20011507A0 (sr) |
HK (1) | HK1068611A1 (sr) |
HR (1) | HRP20040133A2 (sr) |
HU (1) | HUP0400391A3 (sr) |
IL (2) | IL159647A0 (sr) |
MX (1) | MXPA04000267A (sr) |
NO (1) | NO20035821L (sr) |
NZ (1) | NZ530490A (sr) |
PL (1) | PL367958A1 (sr) |
PT (1) | PT1412343E (sr) |
RS (1) | RS50886B (sr) |
UA (1) | UA76168C2 (sr) |
WO (1) | WO2003006452A1 (sr) |
ZA (1) | ZA200400145B (sr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI20030030A0 (fi) * | 2003-01-09 | 2003-01-09 | Orion Corp | Uusia yhdisteitä |
ZA200707427B (en) | 2005-03-11 | 2008-11-26 | Florey Howard Inst | Flavonoid compounds and uses thereof |
US8912224B2 (en) | 2011-09-12 | 2014-12-16 | Sanofi | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
JP5941637B2 (ja) * | 2011-09-12 | 2016-06-29 | サノフイ | 置換2−(クロマン−6−イルオキシ)−チアゾール及び医薬としてのその使用 |
SG11201400518RA (en) * | 2011-09-12 | 2014-04-28 | Sanofi Sa | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
PT2567958E (pt) | 2011-09-12 | 2015-01-14 | Sanofi Sa | 2-(croman-6-iloxi)-tiazoles substituídos e sua utilização como produtos farmacêuticos |
CN102993195B (zh) * | 2011-09-14 | 2017-05-17 | 赛诺菲 | 取代的2‑(色满‑6‑基氧基)噻唑及其作为药物的用途 |
CN103030646B (zh) * | 2011-09-29 | 2016-08-24 | 上海恒瑞医药有限公司 | 苯并二氧六环类衍生物、其制备方法及其在医药上的应用 |
TWI633095B (zh) * | 2013-03-08 | 2018-08-21 | 賽諾菲公司 | 經取代-6-基氧基-環烷類及其作為醫藥品之用途 |
GB201416186D0 (en) | 2014-09-12 | 2014-10-29 | Redx Pharma Ltd | Compounds |
WO2019175464A1 (en) | 2018-03-14 | 2019-09-19 | Orion Corporation | Compounds useful as inhibitors of sodium-calcium exchanger (ncx) |
JP2023535790A (ja) | 2020-07-28 | 2023-08-21 | ジャズ ファーマシューティカルズ アイルランド リミテッド | 縮合二環式raf阻害薬及びその使用方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2820817A (en) * | 1954-02-04 | 1958-01-21 | Mcneilab Inc | Oxygenated indan compounds and method of making the same |
US3862232A (en) * | 1963-07-03 | 1975-01-21 | Upjohn Co | 1-(p-hydroxyphenyl)-2-phenyl-6-(2-diethylaminoethoxy)-3,4-dihydronaphthalene and the salts thereof |
BE650081A (sr) * | 1963-07-03 | |||
GB1154119A (en) * | 1968-05-20 | 1969-06-04 | Merck Ag E | 3-Alkyl-Flavanones |
FR2733685B1 (fr) * | 1995-05-05 | 1997-05-30 | Adir | Utilisation des derives du benzopyrane pour l'obtention de compositions pharmaceutiques destinees au traitement des pathologies liees a l'echangeur c1-/hc03-, na+ independant |
JPH0967336A (ja) | 1995-09-04 | 1997-03-11 | Kanebo Ltd | 新規なイソチオウレア誘導体 |
ATE230720T1 (de) | 1997-03-27 | 2003-01-15 | Taisho Pharmaceutical Co Ltd | 2-phenoxyanilinderivate |
JPH1149752A (ja) * | 1997-08-05 | 1999-02-23 | Taisho Pharmaceut Co Ltd | フェノキシピリジン誘導体 |
DE19742508A1 (de) | 1997-09-26 | 1999-04-01 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
ATE231487T1 (de) * | 1997-10-20 | 2003-02-15 | Taisho Pharmaceutical Co Ltd | 2-phenoxyanilin-derivate |
JPH11302235A (ja) | 1998-04-15 | 1999-11-02 | Taisho Pharmaceut Co Ltd | フェノキシアルキルアミン誘導体 |
EP1180029A4 (en) * | 1999-04-23 | 2002-10-02 | Bristol Myers Squibb Co | BICYCLIC ACYL IHIBITORING SODIUM / PROTON EXCHANGER AND RELATED PROCEDURE. |
AU766935B2 (en) | 1999-09-17 | 2003-10-23 | Nissan Chemical Industries Ltd. | Benzopyran derivative |
FI20030030A0 (fi) | 2003-01-09 | 2003-01-09 | Orion Corp | Uusia yhdisteitä |
-
2001
- 2001-07-10 FI FI20011507A patent/FI20011507A0/fi unknown
-
2002
- 2002-07-10 MX MXPA04000267A patent/MXPA04000267A/es active IP Right Grant
- 2002-07-10 US US10/482,396 patent/US7425568B2/en not_active Expired - Fee Related
- 2002-07-10 PT PT02755036T patent/PT1412343E/pt unknown
- 2002-07-10 PL PL02367958A patent/PL367958A1/xx unknown
- 2002-07-10 DK DK02755036T patent/DK1412343T3/da active
- 2002-07-10 AR ARP020102586A patent/AR036236A1/es unknown
- 2002-07-10 EP EP02755036A patent/EP1412343B1/en not_active Expired - Lifetime
- 2002-07-10 WO PCT/FI2002/000621 patent/WO2003006452A1/en active IP Right Grant
- 2002-07-10 AT AT02755036T patent/ATE338038T1/de not_active IP Right Cessation
- 2002-07-10 CN CNB028138635A patent/CN1281597C/zh not_active Expired - Fee Related
- 2002-07-10 ES ES02755036T patent/ES2269746T3/es not_active Expired - Lifetime
- 2002-07-10 AU AU2002321339A patent/AU2002321339B2/en not_active Ceased
- 2002-07-10 JP JP2003512224A patent/JP4113839B2/ja not_active Expired - Fee Related
- 2002-07-10 CA CA2452918A patent/CA2452918C/en not_active Expired - Fee Related
- 2002-07-10 IL IL15964702A patent/IL159647A0/xx active IP Right Grant
- 2002-07-10 RS YUP-6/04A patent/RS50886B/sr unknown
- 2002-07-10 KR KR10-2004-7000332A patent/KR20040025697A/ko not_active Application Discontinuation
- 2002-07-10 HU HU0400391A patent/HUP0400391A3/hu unknown
- 2002-07-10 NZ NZ530490A patent/NZ530490A/en not_active IP Right Cessation
- 2002-07-10 BR BR0211070-9A patent/BR0211070A/pt not_active IP Right Cessation
- 2002-07-10 EA EA200400161A patent/EA006580B1/ru not_active IP Right Cessation
- 2002-07-10 DE DE60214388T patent/DE60214388T2/de not_active Expired - Fee Related
- 2002-10-07 UA UA2004020928A patent/UA76168C2/uk unknown
-
2003
- 2003-12-23 NO NO20035821A patent/NO20035821L/no not_active Application Discontinuation
- 2003-12-30 IL IL159647A patent/IL159647A/en not_active IP Right Cessation
-
2004
- 2004-01-08 ZA ZA200400145A patent/ZA200400145B/en unknown
- 2004-02-09 HR HR20040133A patent/HRP20040133A2/hr not_active Application Discontinuation
-
2005
- 2005-01-27 HK HK05100708A patent/HK1068611A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS6971A (is) | Ný efnasambönd | |
ATE402148T1 (de) | Substituierte pyridinylamine | |
IS7016A (is) | Ný 4-anilínókínólín-3-karboxamíð | |
DE50206892D1 (de) | Substituierte imidazotriazinone | |
FI20030030A0 (fi) | Uusia yhdisteitä | |
DK1373228T3 (da) | Substituerede fluoralkoxyphenylsulfonylurinstoffer | |
FI20011507A0 (fi) | Uusia yhdisteitä | |
DE50213651D1 (de) | Substituierte 4-aminocyclohexanole | |
DE60216967D1 (de) | Substituierte cyclohexanderivate | |
AT500276B8 (de) | Radschwenksystem | |
SE0100178D0 (sv) | Nya substanser | |
SE0102386D0 (sv) | New compounds | |
SE0100272D0 (sv) | New compounds | |
SE0101660D0 (sv) | New compounds | |
SE0103437D0 (sv) | New compounds | |
SE0103461D0 (sv) | New compounds | |
SE0101958D0 (sv) | New compounds | |
SE0104342D0 (sv) | New compounds | |
SE0101659D0 (sv) | New compounds | |
SE0104366D0 (sv) | New compounds | |
SE0102056D0 (sv) | New Compounds | |
SE0100629D0 (sv) | New compounds | |
SE0102618D0 (sv) | Novel compounds | |
SE0104474D0 (sv) | Novel Compounds | |
SE0104472D0 (sv) | Novel Compounds |